These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7209977)

  • 21. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute hepatic failure due to perhexiline maleate].
    Roche J; Fournet J; Meullenet J; Faure H; Massot C
    Nouv Presse Med; 1979 Feb; 8(7):521-2. PubMed ID: 461164
    [No Abstract]   [Full Text] [Related]  

  • 23. Light and electron microscopy of hepatocellular changes in griseofulvin fed mice. Particular reference to Mallory bodies.
    Wessely Z; Shapiro SH; Klavins JV
    Ann Clin Lab Sci; 1979; 9(1):24-36. PubMed ID: 420510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis and acute renal failure following halothane anaesthesia in a patient treated with perhexiline maleate (author's transl)].
    Bournerias F; Margent P; Goulon M
    Nouv Presse Med; 1978 Apr; 7(15):1301. PubMed ID: 662661
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complications after perhexiline maleate and amiodarone chlorhydrate treatment in a same patient: hypoglycemia, polyneuritis and hyperthyroidism (author's transl)].
    Krulik M; Kaloustian E; Audebert AA; Debray J
    Sem Hop; 1980 Feb 18-25; 56(7-8):315-8. PubMed ID: 6246624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxicity following treatment with perhexiline maleate.
    Long JP; Fitzgerald O; Maurer BJ
    Ir Med J; 1980 Jul; 73(7):275-6. PubMed ID: 7440121
    [No Abstract]   [Full Text] [Related]  

  • 27. Heat shock in vivo induces Mallory body formation in drug primed mouse liver.
    Yuan QX; Marceau N; French BA; Fu P; French SW
    Exp Mol Pathol; 1995 Aug; 63(1):63-76. PubMed ID: 8759055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic lesions due to perhexiline maleate (author's transl)].
    Beaugrand M; Poupon R; Lévy VG; Callard P; Lageron A; Lecomte D; Darnis F; Ferrier JP
    Gastroenterol Clin Biol; 1978; 2(6-7):579-88. PubMed ID: 680480
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ultrastructural study of the liver after treatment with perhexiline maleate].
    Serot JM; Floquet A; Penin F; Cuny G; Grignon G
    Sem Hop; 1977 Nov; 53(39):2199-2200. PubMed ID: 204033
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver ganglioside storage after perhexiline maleate.
    Lageron A; Poupon R; de Saint-Maur PP; Lévy VG
    Lancet; 1977 Feb; 1(8009):483. PubMed ID: 65584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fatal acute hepatitis during treatment with perhexiline maleate and bezafibrate].
    Valmalle R; Bacq Y; Furet Y; Dorval E; Barbieux JP; Metman EH
    Gastroenterol Clin Biol; 1989 May; 13(5):530-1. PubMed ID: 2753299
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatitis due to perhexiline maleate. Development of cirrhosis after interruption of the drug. Report of two cases (author's transl)].
    Beaugrand M; Chousterman M; Callard P; Camilleri JP; Petite J; Ferrier JP
    Gastroenterol Clin Biol; 1977 Oct; 1(10):745-50. PubMed ID: 590691
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatic overload of gangliosides after perhexiline maleate. Morphological and biochemical course (author's transl)].
    Lageron A; Lévy VG; Lecomte D; de Saint-Maur PP
    Nouv Presse Med; 1977 Oct; 6(32):2859-64. PubMed ID: 917802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver disease induced by perhexiline maleate.
    Horowitz JD; White HD; Goble AJ
    Med J Aust; 1982 Jul; 2(1):9-10. PubMed ID: 7110022
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of prolonged administration of griseofulvin in mice with reference to sex differences.
    DeMatteis F; Donnelly AJ; Runge WJ
    Cancer Res; 1966 Apr; 26(4):721-6. PubMed ID: 5937528
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment.
    Knasmüller S; Parzefall W; Helma C; Kassie F; Ecker S; Schulte-Hermann R
    Crit Rev Toxicol; 1997 Sep; 27(5):495-537. PubMed ID: 9347226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subacute toxic hepatitis and perhexiline maleates].
    Herne N; Raillat A; Marion J; Le Gall F; Chagnon A
    Nouv Presse Med; 1976 Oct; 5(9 Oct 76):2164-5. PubMed ID: 980780
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mechanism of action, complications, pharmacokinetics and precautions in the use of perhexiline maleate].
    Dudognon P; Beaugrand M; Singlas E; Benaïm R; Uzan C; Meyrier A
    Coeur Med Interne; 1979; 18(1):129-38. PubMed ID: 477264
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light microscopic observation.
    Denk H; Eckerstorfer R; Gschnait F; Konrad K; Wolff K
    Lab Invest; 1976 Oct; 35(4):377-82. PubMed ID: 62098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle and nerve changes induced by perhexiline maleate in man and mice.
    Fardeau M; Tomé FM; Simon P
    Muscle Nerve; 1979; 2(1):24-36. PubMed ID: 232538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.